156 related articles for article (PubMed ID: 34620184)
1. Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis.
Michaan N; Leshno M; Cohen Y; Safra T; Peleg-Hasson S; Laskov I; Grisaru D
Reprod Biol Endocrinol; 2021 Oct; 19(1):153. PubMed ID: 34620184
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
Lipton JH; Zargar M; Warner E; Greenblatt EE; Lee E; Chan KKW; Wong WWL
Hum Reprod; 2020 Feb; 35(2):434-445. PubMed ID: 32099994
[TBL] [Abstract][Full Text] [Related]
3. Cost Effectiveness of Whole Population BRCA Genetic Screening for Cancer Prevention in Israel.
Michaan N; Leshno M; Safra T; Sonnenblick A; Laskov I; Grisaru D
Cancer Prev Res (Phila); 2021 Apr; 14(4):455-462. PubMed ID: 33355193
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Manchanda R; Legood R; Burnell M; McGuire A; Raikou M; Loggenberg K; Wardle J; Sanderson S; Gessler S; Side L; Balogun N; Desai R; Kumar A; Dorkins H; Wallis Y; Chapman C; Taylor R; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
J Natl Cancer Inst; 2015 Jan; 107(1):380. PubMed ID: 25435542
[TBL] [Abstract][Full Text] [Related]
5. Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.
Gamble C; Havrilesky LJ; Myers ER; Chino JP; Hollenbeck S; Plichta JK; Kelly Marcom P; Shelley Hwang E; Kauff ND; Greenup RA
Ann Surg Oncol; 2017 Oct; 24(11):3116-3123. PubMed ID: 28699130
[TBL] [Abstract][Full Text] [Related]
6. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
[TBL] [Abstract][Full Text] [Related]
7. Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage.
Neal SA; Morin SJ; Franasiak JM; Goodman LR; Juneau CR; Forman EJ; Werner MD; Scott RT
Fertil Steril; 2018 Oct; 110(5):896-904. PubMed ID: 30316435
[TBL] [Abstract][Full Text] [Related]
8. Preimplantation genetic testing for monogenic disorders: clinical experience with BRCA1 and BRCA2 from 2010-2021.
Barrett F; Shaw J; Besser AG; Grifo JA; Blakemore JK
J Assist Reprod Genet; 2023 Nov; 40(11):2705-2713. PubMed ID: 37691027
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of IVF with PGT-M/A to prevent transmission of spinal muscular atrophy in offspring of carrier couples.
Khorshid A; Boyd ALH; Behr B; Zhao Q; Alvero R; Bavan B
J Assist Reprod Genet; 2023 Apr; 40(4):793-801. PubMed ID: 36757555
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of preimplantation genetic screening for women older than 37 undergoing in vitro fertilization.
Collins SC; Xu X; Mak W
J Assist Reprod Genet; 2017 Nov; 34(11):1515-1522. PubMed ID: 28748493
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF.
van Heesch MM; van Asselt AD; Evers JL; van der Hoeven MA; Dumoulin JC; van Beijsterveldt CE; Bonsel GJ; Dykgraaf RH; van Goudoever JB; Koopman-Esseboom C; Nelen WL; Steiner K; Tamminga P; Tonch N; Torrance HL; Dirksen CD
Hum Reprod; 2016 Nov; 31(11):2527-2540. PubMed ID: 27907897
[TBL] [Abstract][Full Text] [Related]
12. In vitro fertilization with preimplantation genetic testing for monogenetic diseases versus unassisted conception with prenatal diagnosis for Huntington disease: a cost-effectiveness analysis.
Christensen AA; Parker PB; Hersh AR; Caughey AB; Krieg SA
Fertil Steril; 2022 Jul; 118(1):56-64. PubMed ID: 35618525
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.
Tuffaha HW; Mitchell A; Ward RL; Connelly L; Butler JRG; Norris S; Scuffham PA
Genet Med; 2018 Sep; 20(9):985-994. PubMed ID: 29300376
[TBL] [Abstract][Full Text] [Related]
14. Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops.
Hurry M; Eccleston A; Dyer M; Hoskins P
Int J Technol Assess Health Care; 2020 Apr; 36(2):104-112. PubMed ID: 32423520
[TBL] [Abstract][Full Text] [Related]
15. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.
Capalbo A; Fabiani M; Caroselli S; Poli M; Girardi L; Patassini C; Favero F; Cimadomo D; Vaiarelli A; Simon C; Rienzi LF; Ubaldi FM
Hum Reprod; 2021 Jun; 36(7):2050-2061. PubMed ID: 34021342
[TBL] [Abstract][Full Text] [Related]
16. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles.
Shapira M; Raanani H; Feldman B; Srebnik N; Dereck-Haim S; Manela D; Brenghausen M; Geva-Lerner L; Friedman E; Levi-Lahad E; Goldberg D; Perri T; Eldar-Geva T; Meirow D
Fertil Steril; 2015 Nov; 104(5):1162-7. PubMed ID: 26335130
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of BRCA pre-implantation genetic testing according to the parental mutation origin: a cohort study.
Weizel I; Shavit T; Shuli Y; Adler Lazarovich C; Halevi R; Ben Ari T; Yaacobi-Artzi S; Bentov Y; Feldman B; Hershko Klement A
Reprod Biol Endocrinol; 2024 Jan; 22(1):8. PubMed ID: 38172815
[TBL] [Abstract][Full Text] [Related]
18. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Kemp Z; Turnbull A; Yost S; Seal S; Mahamdallie S; Poyastro-Pearson E; Warren-Perry M; Eccleston A; Tan MM; Teo SH; Turner N; Strydom A; George A; Rahman N
JAMA Netw Open; 2019 May; 2(5):e194428. PubMed ID: 31125106
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of preimplantation genetic testing for aneuploidies.
Somigliana E; Busnelli A; Paffoni A; Vigano P; Riccaboni A; Rubio C; Capalbo A
Fertil Steril; 2019 Jun; 111(6):1169-1176. PubMed ID: 30777289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
